Unity Biotechnology (STU:9U90) FCF Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Unity Biotechnology FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Unity Biotechnology's Free Cash Flow for the three months ended in Mar. 2024 was €-4.77 Mil. Unity Biotechnology's Revenue for the three months ended in Mar. 2024 was €0.00 Mil. Therefore, Unity Biotechnology's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, Unity Biotechnology's current FCF Yield % is -126.13%.

The historical rank and industry rank for Unity Biotechnology's FCF Margin % or its related term are showing as below:

During the past 8 years, the highest FCF Margin % of Unity Biotechnology was -945.97%. The lowest was -22250.00%. And the median was -2897.76%.

STU:9U90's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -144.01
* Ranked among companies with meaningful FCF Margin % only.

Unity Biotechnology FCF Margin % Historical Data

The historical data trend for Unity Biotechnology's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unity Biotechnology FCF Margin % Chart

Unity Biotechnology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-945.94

-22,228.70

Unity Biotechnology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Unity Biotechnology's FCF Margin %

For the Biotechnology subindustry, Unity Biotechnology's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Unity Biotechnology's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Unity Biotechnology's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Unity Biotechnology's FCF Margin % falls into.

Unity Biotechnology FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Unity Biotechnology's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-34.02	/	0
	=	%

Unity Biotechnology's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-4.768	/	0
	=	%

Unity Biotechnology FCF Margin % Related Terms

Thank you for viewing the detailed overview of Unity Biotechnology's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Unity Biotechnology (STU:9U90) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Unity Biotechnology Inc (STU:9U90) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

UBX:USA 9U90:Germany

Address

285 East Grand Avenue, South San Francisco, CA, USA, 94080

Website

https://www.unitybiotechnology.com

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases.

Unity Biotechnology (STU:9U90) Headlines

No Headlines